Myofascial component of cancer pain review.

Breast Neoplasms / epidemiology Cancer Pain / epidemiology Dry Needling / methods Exercise Therapy / methods Head and Neck Neoplasms / epidemiology Humans Mastectomy / adverse effects Myofascial Pain Syndromes / epidemiology Quality of Life Severity of Illness Index Therapy, Soft Tissue / methods Trigger Points / physiopathology
Cancer Myofascial pain Myofascial release Myofascial trigger points Pain Review

Journal

Journal of bodywork and movement therapies
ISSN: 1532-9283
Titre abrégé: J Bodyw Mov Ther
Pays: United States
ID NLM: 9700068

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 12 02 2019
accepted: 12 02 2019
entrez: 20 5 2019
pubmed: 20 5 2019
medline: 17 3 2020
Statut: ppublish

Résumé

Pain is a common complaint of cancer patients, experienced by 38%-85% of patients. Some studies have shown a high incidence of myofascial pain syndrome (MPS) in cancer patients. 1) To estimate the prevalence of MPS in cancer patients; 2) to examine the efficacy of current treatment options for MPS in cancer patients. Narrative review. PubMed, CINAHL, PEDro, and Google Scholar databases were searched from inception until November 2017, for the keywords: cancer; cancer pain; breast cancer; mastectomy; lumpectomy; myofascial pain; trigger points. Trials of any methodological quality were included. All published material with an emphasis on randomized control trials was analyzed. MPS is prevalent in cancer patients who suffer from pain, with a prevalence of between 11.9% and 44.8% in those diagnosed either with neck or head or breast cancer. Clinical studies showed conflicting results. Four interventional studies found that specific treatment for MPS may reduce the prevalence of active myofascial trigger points and therefore decrease pain level, sensitivity, and improve range of motion (in shoulder) in cancer patients. Two recent randomized control trials showed that pressure release of trigger points provides no additional beneficial effects to a standard physical therapy program for upper limb pain and function after breast cancer surgery. We recommend including the evaluation of myofascial pain in routine clinical examination of cancer patients suffering from pain. Future studies are needed to investigate the long- and short-term effect of MPS treatments in cancer patients.

Sections du résumé

BACKGROUND BACKGROUND
Pain is a common complaint of cancer patients, experienced by 38%-85% of patients. Some studies have shown a high incidence of myofascial pain syndrome (MPS) in cancer patients.
AIMS OBJECTIVE
1) To estimate the prevalence of MPS in cancer patients; 2) to examine the efficacy of current treatment options for MPS in cancer patients.
METHODS METHODS
Narrative review. PubMed, CINAHL, PEDro, and Google Scholar databases were searched from inception until November 2017, for the keywords: cancer; cancer pain; breast cancer; mastectomy; lumpectomy; myofascial pain; trigger points. Trials of any methodological quality were included. All published material with an emphasis on randomized control trials was analyzed.
RESULTS RESULTS
MPS is prevalent in cancer patients who suffer from pain, with a prevalence of between 11.9% and 44.8% in those diagnosed either with neck or head or breast cancer. Clinical studies showed conflicting results. Four interventional studies found that specific treatment for MPS may reduce the prevalence of active myofascial trigger points and therefore decrease pain level, sensitivity, and improve range of motion (in shoulder) in cancer patients. Two recent randomized control trials showed that pressure release of trigger points provides no additional beneficial effects to a standard physical therapy program for upper limb pain and function after breast cancer surgery.
CONCLUSIONS CONCLUSIONS
We recommend including the evaluation of myofascial pain in routine clinical examination of cancer patients suffering from pain. Future studies are needed to investigate the long- and short-term effect of MPS treatments in cancer patients.

Identifiants

DOI: 10.1016/j.jbmt.2019.02.011 PMID: 31103113
pubmed: 31103113
pii: S1360-8592(19)30082-8
doi: 10.1016/j.jbmt.2019.02.011
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-315

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Leonid Kalichman (L)

Department of Physical Therapy, Recanati School for Community Health Professions, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel. Electronic address: kalichman@hotmail.com.

Itay Menahem (I)

Department of Physical Therapy, Recanati School for Community Health Professions, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.

Iuly Treger (I)

Rehabilitation Department, Soroka Medical Center, Beer Sheva, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Myofascial component of cancer pain review.
questionsmedicales.fr › États, signes et symptômes pathologiques › Signes et symptômes › Manifestations neurologiques › Douleur cancéreuse › Myofascial component of cancer pain review.
questionsmedicales.fr › Thérapeutique › Puncture sèche › Myofascial component of cancer pain review.
questionsmedicales.fr › Thérapeutique › Techniques de physiothérapie › Traitement par les exercices physiques › Myofascial component of cancer pain review.
questionsmedicales.fr › Tumeurs › Tumeurs par siège › Tumeurs de la tête et du cou › Myofascial component of cancer pain review.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Myofascial component of cancer pain review.
questionsmedicales.fr › Procédures de chirurgie opératoire › Mastectomie › Myofascial component of cancer pain review.
questionsmedicales.fr › Maladies ostéomusculaires › Syndromes de la douleur myofasciale › Myofascial component of cancer pain review.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Myofascial component of cancer pain review.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Enquêtes et questionnaires › Enquêtes de santé › Indicateurs d'état de santé › Acuité des besoins du patient › Indice de gravité de la maladie › Myofascial component of cancer pain review.
questionsmedicales.fr › Thérapeutique › Techniques de physiothérapie › Manipulations de l'appareil locomoteur › Thérapie des tissus mous › Myofascial component of cancer pain review.
questionsmedicales.fr › Régions du corps › Points de déclenchement › Myofascial component of cancer pain review.